We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
An agreement between DHSC and the ABPI on getting the best value and most effective medicines into use more quickly.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
Product Safety Report for FQDVM-branded Red Plush Toy (Model BRB-2029) presenting a high risk of suffocation.
The key terms of the agreement reached between the Department of Health and Social Care, NHS England and the Association of the British Pharmaceutical Industry for a new voluntary scheme.
This consultation considers the proposed review of the statutory scheme to control the cost of branded health service medicines.
An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.
The second annual review of the regulations relating to the statutory scheme for branded medicines pricing.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
This consultation seeks views on proposals to update the statutory scheme to control the cost of branded health service medicines.
Product Safety Report for TS-branded Upholstered Sofas and Chairs presenting a high risk of fire.
Minutes of meetings held between government, NHS England and the ABPI to review the operation of the 2019 voluntary scheme for branded medicines pricing and access.
The outline terms agreed between DHSC and the Association of the British Pharmaceutical Industry (ABPI) for the voluntary scheme.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2020.
Proposed changes to the statutory scheme to control the costs of branded health service medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.